Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Related Information
Registry Information

Alternate Title

Prospective Study of Clinical, Laboratory, Genetic, and Epidemiologic Characterization of Individuals and Families at High Risk for Hematologic Cancers

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
No phase specified	Biomarker/Laboratory analysis, Educational/Counseling/Training, Genetics, Natural history/Epidemiology	Active	Any age	NCI	NCI-02-C-0210 NCT00052234

Special Category: NIH Clinical Center trial, NCI Web site featured trial

Trial Description

Purpose:

Evaluating genetic and environmental factors in individuals and families at high risk of developing hematologic cancer may help doctors plan more effective treatments.

Screening trial to determine if genetic and environmental factors contribute to the development of hematologic cancer in individuals and families at high risk for cancer.

Eligibility:

Eligibility criteria include the following:

• Any age
• Must have had previous hematologic cancer or have known genetic or environmental risk of developing hematologic cancer
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

One family member will complete a questionnaire. Blood samples will be collected and some participants may undergo a physical exam, imaging procedures, and/or biopsies. All participants will receive counseling and education for cancer prevention, risk reduction, and early detection. Participants will be evaluated periodically.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

NCI - Center for Cancer Research

Neil Caporaso, MD, Protocol chair		Ph: 301-496-4377

U.S.A.
Maryland
	Bethesda
	NCI - Division of Cancer Epidemiology and Genetics
		Genetic Epidemiology Branch Referral Nurse	Ph:  800-518-8474
	NCI - Genetic Epidemiology Branch
		Mary McMaster, MD	Ph:  301-496-4375
			Email: mm349q@nih.gov
	Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
		Clinical Trials Office - Warren Grant Magnusen Clinical Center - NCI Clinical Trials Referral Office	Ph:  888-NCI-1937

See All Trial Sites

Related Information

Featured trial article

Registry Information
Official Title		Clinical, Laboratory And Epidemiologic Characterization Of Individuals And Families At High Risk Of Hematologic Cancer
Trial Start Date		2002-06-03
Trial Completion Date		2012-12-31 (estimated)
Registered in ClinicalTrials.gov		NCT00052234
Date Submitted to PDQ		2002-06-26
Information Last Verified		2007-04-05

Back to Top